The World Health Organization made the announcement days after a study based on 96,000 patients linked the drug to higher death rates — and one day after Trump said he stopped taking it.

The World Health Organization announced Sunday that it is pausing trials of hydroxychloroquine, the malaria drug that President Donald Trump said he took as a possible preventative COVID-19 treatment, despite his own government’s warnings about the drug’s potentially life-threatening side effects.

The WHO’s decision came after scientists from six continents linked the drug to higher death rates in a massive study published Friday by the Lancet journal.

Tedros Adhanom Ghebreyesus, WHO Director General, said during a news conference Monday.

The director general made the announcement after the Lancet study, which reviewed data from 96,000 patients and found that taking hydroxychloroquine increased the risk of dying in coronavirus patients by over 35%.

Despite inconclusive studies on the malaria drug, Trump had been pushing hydroxychloroquine as a potential miracle cure for the COVID-19!

The president tweeted about the drug since March at least a dozen times, according to the Trump Twitter Archive, which shows both live and deleted tweets from the president.

The president also said at press conference Monday that he was taking it to protect himself from the deadly virus.

“I happen to be taking it," Trump said.

He said Wednesday that he was likely finishing his regimen by Thursday or Friday, and said in an interview on Sunday that he stopped taking the drug.